Back to methods browser

First-pass extracted concept

3D lymphatic ring assay

Candidate: toolkit itemType: assay method1 source documents1 linked claims
Jump to explainersJump to evidenceJump to sourcesJump to claims
Live refresh every 5sNext refresh in 5s

Extracted Explainers

What the tool is doing

The 3D lymphatic ring assay is used here to measure lymphatic sprouting by cultured decidual lymphatic endothelial cells. In this study it revealed decreased sprouting in severe preeclampsia-derived dLECs relative to controls.

Source 1DOIPubMed

Resources required

The assay requires isolated and cultured dLECs from chorioamniotic membranes. The abstract does not provide additional protocol details.

Source 1DOIPubMed

What problem it solves

It provides a functional readout of lymphangiogenic capacity rather than relying only on marker expression or transcript profiles.

Source 1DOIPubMed

What it does not solve

The abstract does not show that this assay alone explains the molecular cause of impaired sprouting or substitutes for in vivo decidual validation.

Source 1DOIPubMed

Alternatives

The same abstract also reports migration, adhesion, morphological differentiation, gene expression analysis, and dendritic-cell recruitment measurements as complementary approaches.

Source 1DOIPubMed

Evidence Snippets

dLECs from PE pregnancies showed substantially reduced migration, adhesion, morphological differentiation, and decreased lymphatic sprouting in a 3D lymphatic ring assay compared with normal.
Evidence 1Source 1DOIPubMedprovenance

Supporting Sources

Linked Claims

Claim 1functional impairmentsupports2026Source 1DOIPubMed

Decidual lymphatic endothelial cells from severe preeclampsia have reduced migration, adhesion, morphological differentiation, and lymphatic sprouting compared with controls.